The Department of Laboratory Animal Resources (DLAR) is responsible for laboratory animal care and use for 50 peer review funded PIs of Roswell Park Cancer Institute (RPCI). This resource provides specialized animal husbandry, veterinary medical care, animal health surveillance, diagnostic laboratory facilities, many research technical services and resources including genetically-defined mice, a surgical program and technician and faculty training in support of the > 150 IACUC-approved animal use protocols. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Daily animal inventories, currently about 15,000 include a variety of rodent species, rabbits, dogs and farm animals. The Department has 40 members, 100 of whom have achieved certification through the animal Technician Certification Board (ATCB) of the American Association for Laboratory Animal Science (AALAS). The new, four-story 41,000 nsf vivarium is within the new MRC that bridges Carlton Street and is between the Cancer Cell Center with its animal resource and the Research Studies Center. The combination of the two animal holding units provides >52,000 nsf. All mice housed in the new resource are viral antibody free. The basis for the mouse husbandry program is individually ventilated microisolators. Racks are designed too house 108 cages, each ventilated with sterile air and equipped port access with a continuous supply of purified water. A portion of the resource has been designed for ABSL, 2/3 capability for use with rodents. Labs for work with gene knockout and transgenic technologies in mice are immediately adjacent to animal holding rooms. The contiguous Cancer Center Animal Resource is the site of the new 4.7 Tesla CCSG animal research MRI resource and a whole animal cesium irradiation unit. The operating budget is comprised of revenues from institutional sources (74%), chargebacks (13%) and the Cancer Center Support Grant (13%). Continued support through the CCSG will permit DLAR to prove standard of care. and use that meet or exceed applicable state and federal standards, accomplish pursuit of DLAR to prove standard of care and use that meet or exceed applicable state and federal standards, accomplish pursuit of external accreditation (AALACi) and furnish investigators with a comprehensive program for safe, appropriate and cost effective research animal use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016056-26S1
Application #
6588803
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mahoney, Martin C; Erwin, Deborah O; Twarozek, Annamaria Masucci et al. (2018) Leveraging technology to promote smoking cessation in urban and rural primary care medical offices. Prev Med 114:102-106
Cheng, Ting-Yuan David; Darke, Amy K; Redman, Mary W et al. (2018) Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). J Natl Cancer Inst 110:734-742
Zonneville, Justin; Safina, Alfiya; Truskinovsky, Alexander M et al. (2018) TGF-? signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. BMC Cancer 18:670
Rabi, Thangaiyan; Li, Fengzhi (2018) Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition. Am J Cancer Res 8:2267-2283
Haring, Rodney C; Henry, Whitney Ann; Hudson, Maui et al. (2018) Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ 33:44-51
Elahi, Seerat; Egan, Shawn M; Holling, G Aaron et al. (2018) The RNA binding protein Ars2 supports hematopoiesis at multiple levels. Exp Hematol 64:45-58.e9
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :

Showing the most recent 10 out of 1555 publications